Literature DB >> 30406938

Catheter ablation of atrial fibrillation: current status, techniques, outcomes and challenges

Gerhard Hindricks, Alireza Sepehri Shamloo, Radosław Lenarczyk, Zbigniew Kalarus, Arash Arya, Simon Kircher, Angeliki Darma, Nikolaos Dagres1.   

Abstract

Atrial fibrillation (AF) is the most common human arrhythmia. Interventional treatment with catheter ablation is an established technique that is increasingly applied and has become one of the main treatment modalities in patients with AF. Ablation results in significant improvement of symptoms and the quality of life. There is as yet no clear evidence of any impact of the procedure on hard clinical endpoints, except in patients with heart failure, who seem to benefit significantly from ablation. The cornerstone of the procedure is the achievement of pulmonary vein isolation. Radiofrequency energy is the main applied energy source, but cryoballoon ablation has emerged as a safe and effective alternative to radiofrequency ablation. Additional ablation strategies and novel technical features have been proposed but without unequivocal proof of clinical benefit. The most promising of these seems to be substrate mapping of the left atrium with substrate modification in areas with low voltage as an adjunct to pulmonary vein isolation. Complication rates remain considerable despite accumulated experience and can be partly reduced by application of preventive measures.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; complications

Mesh:

Year:  2018        PMID: 30406938     DOI: 10.5603/KP.a2018.0216

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  4 in total

Review 1.  [2020 ESC guidelines on atrial fibrillation : Summary of the most relevant recommendations and innovations].

Authors:  Alireza Sepehri Shamloo; Nikolaos Dagres; Gerhard Hindricks
Journal:  Herz       Date:  2021-02       Impact factor: 1.443

2.  Atrial fibrillation in older adults with cancer.

Authors:  Manish Kumar; Nerea Lopetegui-Lia; Christina Al Malouf; Mansour Almnajam; Patrick P Coll; Agnes S Kim
Journal:  J Geriatr Cardiol       Date:  2022-01-28       Impact factor: 3.327

3.  Risk factors for late recurrence in patients with nonvalvular atrial fibrillation after radiofrequency catheter ablation.

Authors:  Zhang Peng; Liu Wen-Heng; Zhao Qing; Sun Pin; Cai Shang-Lang; Wang Mao-Jing; Pan Ya-Qi
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-12-09       Impact factor: 1.468

Review 4.  Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers.

Authors:  Kun Xiang; Muhammad Akram; Walaa Fikry Elbossaty; Jinfu Yang; Chengming Fan
Journal:  Heart Fail Rev       Date:  2021-07-12       Impact factor: 4.654

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.